ARTICLE | Clinical News
Triumeq dolutegravir/abacavir/lamivudine: Phase IIIb data
August 1, 2016 7:00 AM UTC
Top-line data from the open-label, international Phase IIIb ARIA trial in 495 antiretroviral therapy (ART)-naive women with HIV-1 infection showed that once-daily oral Triumeq met the co-primary endpo...